Intuitive Surgical, the leader in robotic surgery equipment, has over 9,900 da Vinci systems globally, performing 16 million procedures. Revenue comes mainly from servicing and supplies, resulting in dependable, recurring income. The stock has a high forward P/E ratio of 59, reflecting its growth. Medtronic, a competitor in robotic surgery, offers a lower valuation and a 2.8% dividend yield. Its recent earnings beat expectations, showing strong growth potential. The Motley Fool did not include Intuitive Surgical in its top 10 stocks, highlighting potential for other investments. Stock Advisor’s total average return is 981%, outperforming the S&P 500’s 187%. Selena Maranjian has positions in Intuitive Surgical, which the Motley Fool recommends along with Medtronic. 1. The U.S. economy added 943,000 jobs in July, exceeding expectations. Unemployment rate dropped to 5.4%, lowest since the start of the pandemic.
2. Delta variant continues to spread, causing a surge in COVID-19 cases. Florida reports a record-high hospitalization rate, with 10,000 patients currently hospitalized.
3. Tesla’s revenue reached $11.96 billion in Q2, exceeding estimates. The company delivered 201,250 vehicles in the quarter, a new record.
Read more at Yahoo Finance: What Are the Best Healthcare Stocks to Buy Now? I Think It’s Intuitive Surgical (ISRG) — or, to Play It Safer, Medtronic (MDT)
